Chemfab Alkalis has notified the stock exchanges of an upcoming Board of Directors meeting, scheduled for Wednesday, May 13, 2026, at 2:00 P.M. The intimation has been filed pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR), as amended. The board meeting will deliberate on key financial and corporate matters pertaining to the quarter and full financial year ended March 31, 2026.

Agenda for the Board Meeting

The board is set to consider and approve the following key items during the meeting:

The board will review and approve the audited standalone and consolidated financial statements for the quarter and financial year ended March 31, 2026. Additionally, the board will consider the declaration of a dividend, which, if approved, will be subject to shareholder approval.

Trading Window Closure

In continuation of its earlier communication dated March 25, 2026, the company has reiterated the closure of the Trading Window in accordance with the Company's Code of Prevention of Insider Trading, read with SEBI (Prohibition of Insider Trading) Regulations, 2015. The key details of the Trading Window closure are as follows:

• Closure Start Date: April 01, 2026
• Closure End Date: May 15, 2026 (48 hours after the declaration of audited financial results)
• Applicable Parties: Directors, Designated Employees, other insiders of the Company, and their relatives

The Trading Window will remain closed for dealing in the company's shares until 48 hours after the declaration of the audited financial results for the quarter and financial year ended March 31, 2026, effectively until May 15, 2026.

Company Background

Chemfab Alkalis is an OHSAS 18001 and ISO 14001 certified company, registered under CIN No. L24290TN2009PLC071563. The company is a member of Dr. Rao's Group of Companies, with its registered office at 'TEAM House', GST Road, Vandalur, Chennai - 600 048, and its plant located at "Gnanananda Place", Kalapet, Puducherry - 605 014. The intimation was signed by Bharatraj Panchal, Company Secretary (FCS: 9828), on May 07, 2026.

Chemfab Alkalis Limited's promoters and substantial shareholders have submitted regulatory declarations confirming compliance with SEBI's share encumbrance requirements for the financial year 2025-26. The declarations were filed under Regulation 31(4) of SEBI (Substantial Acquisition of Shares & Takeover) (Second Amendment) Regulation, 2019.

Regulatory Compliance Framework

The declarations serve as mandatory compliance under SEBI's takeover regulations, requiring promoters and substantial shareholders to formally confirm the non-encumbrance status of their shareholdings. This regulatory requirement ensures transparency in share ownership and prevents unauthorized pledging or encumbrance of shares that could impact corporate governance.

Promoter Declaration

Ramachandran N, in his capacity as promoter, submitted a declaration stating that he does not hold any shares in Chemfab Alkalis Limited. He confirmed that the provisions on encumbrance under Regulation 31(4) are not applicable to him and declared no encumbrance on shares along with persons acting in concert during the financial year 2025-26.

Substantial Shareholders Declarations

Four key substantial shareholders also submitted their declarations, representing both individual and corporate entities of the company.

Filing Parameters

The regulatory filings demonstrate coordinated compliance across all promoters and substantial shareholders.

The synchronized filing of these declarations reflects the company's systematic approach to regulatory compliance and corporate governance standards. Each declaration was duly signed by the respective stakeholders or their authorized representatives, maintaining the formal requirements under SEBI regulations.